Editorial e159 Forging ahead on fibromyalgia The Lancet Rheumatology +++ +...

Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial Prof Andrew P Cope, MDa andrew.cope@kcl.ac.uk ∙ Marianna Jasenecova, MSca ∙ Joana C Vasconcelos, MScb ∙ Sumera Qureshi, MDa ∙ Dr Karin A van Schie, PhDm ∙ Prof Andrew Filer, MDd ∙ et al. S https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00371-6/fulltext?dgcid=hubspot_update_feature_updatealerts_lanrhe&utm_campaign=update-lanrhe&utm_medium=email&_hsenc=p2ANqtz-9OP--HQzGmo9zM2_U9WtSMAfpL4BLP2TzPHagzXUFnfPbjUALFJ1BpiDRPBeTx4D4VIph6kYTD3VZ-hL8VgfZyrvSN7w&_hsmi=408213663&utm_content=408213663&utm_source=hs_email Cardiovascular risk factor control in antiphospholipid syndrome, and differences between primary and systemic lupus erythematosus-related antiphospholipid syndrome (SURF-SLE and APS project): a cross-sectional study of 1003 individuals from 11 countries Eleana Bolla, MDa ∙ Anne Grete Semb, MDb ∙ Prof Michelle Petri, MDc ∙ Prof Petros P Sfikakis, MDa ∙ Bahar Artim-Esen, MDd ∙ Gabriela Hernandez-Molina, MDe ∙ et al. https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00257-7/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-88t3RL3WKMf8shxLPZ6WRT-2-b0G5grIv39-ldLgWiw7Ce4DLrHzffAhjxCusG5GxfXFY5GgRiABDLDEwEcEkjaFPg6w&_hsmi=408213663&utm_content=408213663&utm_source=hs_email The path to interception in psoriatic disease: from conceptual clarity to clinical translation Dylan McGagh, BMBCha,b dylan.mcgagh@ndorms.ox.ac.uk ∙ Ashley Elliott, PhDc ∙ Teresa Grohmann, PhDd ∙ Wendy Wagenaar, PhDe,f ∙ Prof Stephen R Pennington, PhDd ∙ Prof Oliver FitzGerald, MDd ∙ et al. https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00348-0/abstract?utm_campaign=update-lanrhe&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanrhe&_hsenc=p2ANqtz-9R9O0_Nk6S1aWrTrKz88nubYA81bj-XOi_82HkYAdZ21EjNKU0pM36Yhnmmt9du1vA1rlFkxKF10JreYvAJqE-5s7r_Q&_hsmi=408213663&utm_content=408213663&utm_source=hs_email Editorial e159 Forging ahead on fibromyalgia The Lancet Rheumatology https://www.thelancet.com/journals/lanrhe/issue/vol8no3/PIIS2665-9913(26)X2002-1